Goodman Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Hold |
647
| – | – | 0.01% | 97 |
|
|
2025
Q1 | $39.5K | Buy |
+647
| New | +$39.5K | 0.01% | 112 |
|
|
2024
Q4 | – | Sell |
-647
| Closed | -$33.5K | – | 68 |
|
|
2024
Q3 | $33.5K | Hold |
647
| – | – | 0.01% | 127 |
|
|
2024
Q2 | $26.9K | Hold |
647
| – | – | 0.01% | 129 |
|
|
2024
Q1 | $35.1K | Hold |
647
| – | – | 0.01% | 107 |
|
|
2023
Q4 | $33.2K | Hold |
647
| – | – | 0.01% | 99 |
|
|
2023
Q3 | $37.6K | Hold |
647
| – | – | 0.01% | 98 |
|
|
2023
Q2 | $41.4K | Sell |
647
-4
| -0.6% | -$256 | 0.02% | 89 |
|
|
2023
Q1 | $45.1K | Hold |
651
| – | – | 0.02% | 78 |
|
|
2022
Q4 | $47K | Hold |
651
| – | – | 0.03% | 76 |
|
|
2022
Q3 | $46K | Hold |
651
| – | – | 0.03% | 75 |
|
|
2022
Q2 | $50K | Buy |
+651
| New | +$50K | 0.02% | 76 |
|